Synergistic Effects of Type 2 Diabetes and Alcohol on All‐Cause and Liver‐Related Mortality in Steatotic Liver Disease
Alimentary Pharmacology & Therapeutics · 2026-07 · 64 (2) · 243-254
DOI: 10.1111/apt.70683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 03.05.2026. Verfasst von Ruoqi Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Inn…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Alcohol Drinking, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang, National Natural Science Foundation of China, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes (T2D) and alcohol consumption are well‐established risk factors for adverse clinical outcomes among individuals with steatotic liver disease (SLD). However, data about the synergistic effects of T2D and alcohol on all‐cause and liver‐related mortality in SLD remain scarce.
Method
Leveraging data from UK Biobank and U.S. NHANES, we assessed risks of all‐cause and liver‐related mortality across 6 groups stratified by T2D status and SLD spectrum using Cox proportional hazards models: no T2D + MASLD, no T2D + MetALD, no T2D + ALD, T2D + MASLD, T2D + MetALD and T2D + ALD. The population attributable fraction (PAF) and relative excess risk due to interaction (RERI) were calculated to examine the interplay between these two factors.
Results
24,052 all‐cause and 953 liver‐related deaths were recorded for 174,711 participants from the UK Biobank. The coexistence of T2D and elevated alcohol intake, particularly when with T2D and ALD, was associated with substantially worse outcomes, including a 1.23–1.60 fold increased risk of all‐cause mortality and a markedly higher 1.65–7.45 fold risk of liver‐related mortality compared with no T2D + MASLD. The combined effect of T2D and alcohol use accounted for a modest PAF of 6.74% for all‐cause mortality, but they contributed to a PAF of 41.63% for liver‐related mortality. Significant RERI was exclusively observed for liver‐related mortality, but not for all‐cause mortality.
Conclusions
Co‐exposure to T2D and alcohol intake substantially increased the risk of all‐cause and liver‐related mortality among individuals with SLD. Their interplay conferred significant disease burden, underscoring the importance of alcohol abstinence and glycemic control in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The…
- Guangdong Provincial Key Laboratory of Food, Nutrition and Health, and Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Hepatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
- Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrinology and Metabolic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- MAFLD Research Centre, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Fanpu Ji, Rongtao Lai, Ming-Hua Zheng, Vincent Wai-Sun Wong, Yu Shi, Xinrong Zhang
Förderung
- Key Research and Development Program of Zhejiang
- National Natural Science Foundation of China
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Medical Science and Technology Project of Zhejiang Province
- Young Scholar Training Program of Sun Yat-Sen University
Zitieren
APA
Zhou, R., Tu, H., Ji, F., Lai, R., Wang, J., Su, J., Tao, J., Feng, Y., Zhang, H., Zheng, M. H., Wong, V. W., Shi, Y., & Zhang, X. (2026). Synergistic Effects of Type 2 Diabetes and Alcohol on All‐Cause and Liver‐Related Mortality in Steatotic Liver Disease. Alimentary Pharmacology & Therapeutics, 64(2), 243-254. https://doi.org/10.1111/apt.70683
Vancouver
Zhou R, Tu H, Ji F, Lai R, Wang J, Su J, et al. Synergistic Effects of Type 2 Diabetes and Alcohol on All‐Cause and Liver‐Related Mortality in Steatotic Liver Disease. Alimentary Pharmacology & Therapeutics. 2026;64(2):243-254. doi:10.1111/apt.70683
BibTeX
@article{Zhou2026,
author = {Zhou, Ruoqi and Tu, Huilan and Ji, Fanpu and Lai, Rongtao and Wang, Jie and Su, Junwei and Tao, Jingjing and Feng, Ye and Zhang, Haotian and Zheng, Ming-Hua and Wong, Vincent Wai-Sun and Shi, Yu and Zhang, Xinrong},
title = {Synergistic Effects of Type 2 Diabetes and Alcohol on All‐Cause and Liver‐Related Mortality in Steatotic Liver Disease},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {2},
pages = {243--254},
doi = {10.1111/apt.70683}
}
EUVIMED